Applications for Nigeria Jubilee Fellows Programme 2.0 have reopened, offering graduates nationwide a chance to gain hands-on ...

PHILADELPHIA & SAN FRANCISCO, January 12, 2026--(BUSINESS WIRE)--Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare platform, ...

The National Drug Law Enforcement Agency (NDLEA) has unveiled an online portal for drug integrity tests, visa clearance certificates. The initiative is set to make the clearance process seamless and ...

FDA classifies medical devices based on the type of device and the level of risk it poses Three main FDA clearances for medical devices are 510(k), de novo and pre-market approval Several ASX ...

SAN FRANCISCO, CA / ACCESS Newswire / August 4, 2025 / CASI Pharmaceuticals, Inc. (CASI), a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with organ ...

NEW TAIPEI CITY, July 28, 2025 /PRNewswire/ -- Caliway Biopharmaceuticals (TWSE: 6919) today announced that the U.S. Food and Drug Administration (FDA) has granted clearance to proceed with SUPREME-01 ...

Australia's new competition merger clearance regime is now live. It can now be used on a voluntary basis and becomes mandatory from 1 January 2026 for all acquisitions of shares or assets that meet ...

DOVER, Del., June 20, 2025 /PRNewswire/ -- Lomond Therapeutics Holdings, Inc. ("Lomond Therapeutics"), a clinical-stage biotechnology company dedicated to discovering and developing potentially ...

San Diego, California--(Newsfile Corp. - June 11, 2025) - Thiogenesis Therapeutics, Corp. (TTI:CA) (OTCQX: TTIPF) ('Thiogenesis' or the 'Company') a clinical-stage biotechnology company developing ...

(RTTNews) - Erasca, Inc. (ERAS) announced clearance of an investigational new drug application by the FDA for ERAS-4001, a potential first-in-class and best-in-class pan-KRAS inhibitor, for the ...